quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:04·336d
SECFiling
ACELYRIN INC. logo

SEC Form EFFECT filed by ACELYRIN INC.

SLRN· ACELYRIN INC.
Health Care
Original source

Companies

  • SLRN
    ACELYRIN INC.
    Health Care

Recent analyst ratings

  • Aug 14UpdateH.C. Wainwright$6.00
  • Jul 8UpdateWells Fargo$13.00
  • Dec 13UpdateWells Fargo$11.00
  • Dec 8UpdateCitigroup$8.00
  • Sep 13UpdateMorgan Stanley$19.00
  • Sep 5UpdateH.C. Wainwright$44.00

Related

  • INSIDER335d
    Director Ayurmaya Capital Management Company, Lp returned 9,334,735 shares to the company (SEC Form 4)
  • SEC335d
    Amendment: SEC Form SCHEDULE 13D/A filed by ACELYRIN INC.
  • INSIDER335d
    Chief Executive Officer Kim Mina was granted 89,526 shares and returned 770,833 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER335d
    SEC Form 4 filed by Director Cozadd Bruce C
  • INSIDER335d
    Chief Legal Officer Murugan Amar returned 121,587 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER335d
    Director Seidenberg Beth C returned 9,850,729 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER335d
    Chief Medical Officer Mpofu Shephard returned 121,789 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER335d
    Director Gosebruch Henry O returned 50,000 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022